Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Positron emission tomography studies of human airways using an inhaled beta-adrenoceptor antagonist, S-11C-CGP 12388.

van Waarde A, Maas B, Doze P, Slart RH, Frijlink HW, Vaalburg W, Elsinga PH.

Chest. 2005 Oct;128(4):3020-7.

PMID:
16236982
2.

PET imaging of beta-adrenoceptors in human brain: a realistic goal or a mirage?

van Waarde A, Vaalburg W, Doze P, Bosker FJ, Elsinga PH.

Curr Pharm Des. 2004;10(13):1519-36. Review.

PMID:
15134573
3.

Quantification of beta-adrenoceptor density in the human heart with (S)-[11C]CGP 12388 and a tracer kinetic model.

Doze P, Elsinga PH, van Waarde A, Pieterman RM, Pruim J, Vaalburg W, Willemsen AT.

Eur J Nucl Med Mol Imaging. 2002 Mar;29(3):295-304.

PMID:
12002702
4.

Synthesis and evaluation of (S)-[18F]-fluoroethylcarazolol for in vivo beta-adrenoceptor imaging in the brain.

Doze P, van Waarde A, Tewson TJ, Vaalburg W, Elsinga PH.

Neurochem Int. 2002 Jul;41(1):17-27.

PMID:
11918968
5.

Imaging of beta-adrenoceptors in the human thorax using (S)-[(11)C]CGP12388 and positron emission tomography.

Elsinga PH, Doze P, van Waarde A, Pieterman RM, Blanksma PK, Willemsen AT, Vaalburg W.

Eur J Pharmacol. 2001 Dec 21;433(2-3):173-6.

PMID:
11755150
6.

Synthesis and evaluation of radiolabeled antagonists for imaging of beta-adrenoceptors in the brain with PET.

Doze P, Elsinga PH, Maas B, Van Waarde A, Wegman T, Vaalburg W.

Neurochem Int. 2002 Feb;40(2):145-55.

PMID:
11738481
7.

Influence of P-glycoprotein on brain uptake of [18F]MPPF in rats.

Passchier J, van Waarde A, Doze P, Elsinga PH, Vaalburg W.

Eur J Pharmacol. 2000 Nov 3;407(3):273-80.

PMID:
11068023
8.

Mutagenic activity of a fluorinated analog of the beta-adrenoceptor ligand carazolol in the Ames test.

Doze P, Elsinga PH, de Vries EF, Van Waarde A, Vaalburg W.

Nucl Med Biol. 2000 Apr;27(3):315-9.

PMID:
10832089
9.

Synthesis and biodistribution of [11c]procaterol, a beta2-adrenoceptor agonist for positron emission tomography.

Visser TJ, van der Wouden EA, van Waarde A, Doze P, Elsinga PH, Vaalburg W.

Appl Radiat Isot. 2000 Apr;52(4):857-63.

PMID:
10800722
10.

Monitoring of herpes simplex virus thymidine kinase enzyme activity using positron emission tomography.

Hospers GA, Calogero A, van Waarde A, Doze P, Vaalburg W, Mulder NH, de Vries EF.

Cancer Res. 2000 Mar 15;60(6):1488-91.

11.

Enhanced cerebral uptake of receptor ligands by modulation of P-glycoprotein function in the blood-brain barrier.

Doze P, Van Waarde A, Elsinga PH, Hendrikse NH, Vaalburg W.

Synapse. 2000 Apr;36(1):66-74.

PMID:
10700027
13.

Characterisation of beta2-adrenoceptors, using the agonist [11C]formoterol and positron emission tomography.

Visser TJ, van Waarde A, Doze P, Elsinga PH, van der Mark TW, Kraan J, Ensing K, Vaalburg W.

Eur J Pharmacol. 1998 Nov 13;361(1):35-41.

PMID:
9851539
14.

Validation of S-1'-[18F]fluorocarazolol for in vivo imaging and quantification of cerebral beta-adrenoceptors.

Doze P, Van Waarde A, Elsinga PH, Van-Loenen Weemaes AM, Willemsen AT, Vaalburg W.

Eur J Pharmacol. 1998 Jul 24;353(2-3):215-26.

PMID:
9726651
15.

A novel beta-adrenoceptor ligand for positron emission tomography: evaluation in experimental animals.

van Waarde A, Elsinga PH, Doze P, Heldoorn M, Jaeggi KA, Vaalburg W.

Eur J Pharmacol. 1998 Feb 19;343(2-3):289-96.

PMID:
9570478

Supplemental Content

Support Center